Peptide hormone binding to G-protein-coupled receptors: Structural characterization via NMR techniques

Medicinal Research Reviews

Volumn 21, Issue 5, 2001, Pages 450-471

  Mierke, Dale F ^a   Giragossian, Craig ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

CCK1; Cholecystokinin; G protein coupled receptors; NMR structural characterization; Peptide hormones

Indexed keywords

CALCIUM; CHOLECYSTOKININ; G PROTEIN COUPLED RECEPTOR; NEUROTRANSMITTER; PEPTIDE HORMONE; RHODOPSIN;

CONFERENCE PAPER; HORMONE RECEPTOR INTERACTION; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; GTP-BINDING PROTEINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; RECEPTORS, CHOLECYSTOKININ;

EID: 0034890108     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.1018     Document Type: Conference Paper

References (156)

1. The probable arrangement of the helices in G protein-coupled receptors
2. Expanding horizons for receptors coupled to G proteins: Diversity and disease
3. GCRDb: A G-protein-coupled receptor database
4. GPCRDB: An information system for G protein-coupled receptors
5. Johnson & Johnson finds an elusive gene and races to exploit it
6. The impact of genomics on drug discovery
7. Partial agonism through a zinc-Ion switch constructed between transmembrane domains III and VII in the tachykinin NK(1) receptor
8. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors
9. Structure-activity relationships of G protein-coupled receptors
10. Molecular modelling studies on G protein-coupled receptors: From sequence to structure?
11. Minireview: Insights into G protein-coupled receptor function using molecular models
12. Analysis of membrane and surface protein sequences with the hydrophobic moment plot
13. A simple method for displaying the hydropathic character of a protein
14. Model for the structure of bacteriorhodopsin based on high-resolution electron cryomicroscopy
15. X-ray structure of bacteriorhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases
16. Projection structure of rhodopsin
17. Projection structure of frog rhodopsin in two crystal forms
18. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors
19. Arrangement of rhodopsin transmembrane alphahelices
20. Crystal structure of rhodopsin: A G protein-coupled receptor
21. What if
22. Modeling alpha-helical transmembrane domains: The calculation and use of substitution tables for lipid-facing residues
23. The prediction and orientation of alpha-helices from sequence alignments: The combined use of environment-dependent substitution tables, Fourier transform methods and helix capping rules
24. Structure and function of G protein-coupled receptors
25. The role of histidine 265 in antagonist binding to the neurokinin-1 receptor
26. Specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345
27. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor
28. Engineering of metal-ion sites as distance constraints in structural and functional analysis of 7TM receptors
29. Modeling of G-protein-coupled receptors: Application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors
30. A proposed model of bradykinin bound to the rat B2 receptor and its utility for drug design
31. Molecular modelling of CCK-A receptors
32. Arrangement of transmembrane domains in adrenergic receptors. Similarity to bacteriorhodopsin
33. Proposed arrangement of the seven transmembrane helices in the secretin receptor family
34. Natural agonist enhancing bis-His zinc-site in transmembrane segment V of the tachykinin NK3 receptor
35. Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation
36. Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands
37. Structural features and light-dependent changes in the sequence 306-322 extending from helix VII to the palmitoylation sites in rhodopsin: A site-directed spin-labeling study
38. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling
39. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: A site-directed spin labeling study
40. Peptide mimetic of the third intracellular loop of the PTH/PTHrP receptor
41. Conformational characterization of a peptide mimetic of the third cytoplasmic loop of the G-protein-coupled parathyroid hormone/parathyroid hormone related protein receptor
42. Binding domain of human parathyroid hormone receptor: From conformation to function
43. The molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy
44. Characterization of parathyroid hormone/receptor interactions: Structure of the first extracellular loop
45. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor
46. Three-dimnesional structure for the b2 adrenergic receptor protein based on computer modeling studies
47. Molecular basis of muscarininc acetylcholine receptor function
48. Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists
49. How receptors talk to trimeric G proteins
50. G protein-coupled receptors in silico
51. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
52. Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta2-adrenergic receptor
53. Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis
54. The peptide binding site of the substance P (NK-1) receptor localized by a photoreactive analogue of substance P: Presence of a disulfide bond
55. The N terminus of bradykinin when bound to the human bradykinin B2 receptor is adjacent to extracellular Cys20 and Cys277 in the receptor
56. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines
57. Disulfide bridges in interleukin-8 probed using non-natural disulfide analogues: Dissociation of roles in structure from function
58. International union of pharmacology. XXII. Nomenclature for chemokine receptors
59. Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding
60. The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern
61. Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies
62. Motif mutation of bradykinin B2 receptor second intracellular loop and proximal C terminus is critical for signal transduction, internalization, and resensitization
63. Molecular characterization of the receptor-ligand complex for parathyroid hormone
64. Basic local alignment search tool
65. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
66. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation
67. A molecular dynamics study of the decane/water interface
68. GROMACS: A message passing parallel molecular dynamics implementation
69. Addressing the tertiary structure of human parathyroid hormone-(1-34)
70. Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex
71. Structural insight into the role of the second intracellular loop of the bradykinin 2-receptor in signaling and internalization
72. Towards 3D structures of G protein-coupled receptors: A multidisciplinary approach
73. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
74. Crystal structure of the ectodomain of Methuselah, a Drosophila G protein-coupled receptor associated with extended lifespan
75. Path of the polypeptide chain in bacteriorhodopsin
76. Lipidic cubic phases: A novel concept for the crystallization of membrane proteins
77. Detergent-free membrane protein crystallization
78. Membrane protein crystallization in lipidic mesophases: Detergent effects
79. A lipid's eye view of membrane protein crystallization in mesophases
80. Crystallization in cubo: General applicability to membrane proteins
81. Lipidic cubic phase crystallization of bacteriorhodopsin and cryotrapping of intermediates: Towards resolving a revolving photocycle
82. Structural changes in bacteriorhodopsin during ion transport at 2 angstrom resolution
83. Coupling photo-isomerization of retinal to directional transport in bacteriorhodopsin
84. High-resolution X-ray structure of an early intermediate in the bacteriorhodopsin photocycle
85. Helix deformation is coupled to vectorial proton transport in the photocycle of bacteriorhodopsin
86. Helix-coil transition of the isolated amino terminus of ribonuclease
87. Folding of peptide fragments comprising the complete sequence of proteins. Models for initiation of protein folding. I. Myohemerythrin
88. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin
89. Regulation of retinal transducin by C-terminal peptides of rhodopsin
90. C-terminal peptides of rhodopsin. Determination of the optimum sequence for recognition of retinal transducin
91. Three cytoplasmic loops of rhodopsin interact with transducin
92. Structure of the third cytoplasmic loop of bovine rhodopsin
93. Synthetic peptides corresponding to residues 551 to 555 and 650 to 653 of the rat testicular follicle-stimulating hormone (FSH) receptor are sufficient for post-receptor modulation of Sertoli cell responsiveness to FSH stimulation
94. Structure of the C-terminal fragment 300-320 of the rat angiotensin II AT1A receptor and its relevance with respect to G-protein coupling
95. Solution structure of the second extracellular loop of human thromboxane A2 receptor
96. NMR studies of peptides and proteins associated with membranes
97. Peptide structural analysis by solid-state NMR spectroscopy
98. Physicochemical characterization of glucagon-containing lipid micelles
99. Role of membrane lipids in peptide hormone function: Binding of enkephalins to micelles
100. 13C NMR spectroscopy of alanine methyl groups in detergent-solubilized M13 coat protein
101. Nuclear magnetic resonance investigation of the conformation of delta-haemolysin bound to dodecylphosphocholine micelles
102. Conformational studies by circular dichroism, 1H NMR, and computer simulations of bombolitins I and III in aqueous solution containing surfactant micelles
103. The use of dodecylphosphocholine micelles in solution NMR
104. NMR studies of adrenocorticotropin hormone peptides in sodium dodecylsulfate and dodecylphosphocholine micelles: Proline isomerism and interactions of the peptides with micelles
105. Effect of detergent concentration on multidimensional solution spectra of membrane proteins in micelles
106. Structures of the M2 channel-lining segments from nicotinic acetylcholine and NMDA receptors by NMR spectroscopy
107. Effects of glycosylation on the structure and dynamics of eel calcitonin in micelles and lipid bilayers determined by nuclear magnetic resonance spectroscopy
108. The first and second cytoplasmic loops of the G-protein receptor, rhodopsin, independently form beta-turns
109. Structures of the intradiskal loops and amino terminus of the G-protein receptor, rhodopsin
110. Structure of the carboxy-terminal domain of bovine rhodopsin
111. Structure determination of the fourth cytoplasmic loop and carboxyl terminal domain of bovine rhodopsin
112. Effects of phosphorylation on the structure of the G-protein receptor rhodopsin
113. Solution structure of the sixth transmembrane helix of the G-protein-coupled receptor, rhodopsin
114. Three dimensional structure of the seventh transmembrane helical domain of the G-protein receptor, rhodopsin
115. Three-dimensional structure of the highly conserved seventh transmembrane domain of G-protein-coupled receptors
116. NMR and circular dichroism studies of synthetic peptides derived from the third intracellular loop of the beta-adrenoceptor
117. Conformation of a beta-adrenoceptor-derived signal transducing peptide as inferred by circular dichroism and 1H NMR spectroscopy
118. Structural characterization of peptide hormone/receptor interactions by NMR spectroscopy
119. Parathyroid hormone and parathyroid hormone-related protein: Model systems for the development of an osteoporosis therapy
120. Membrane lipid phase as catalyst for peptide-receptor interaction
121. Peptide-membrane interactions and a new principle in quantitative structure-activity relationships
122. How do peptides interact with lipid membranes and how does this affect their biological activity
123. In search of the 'bio-active conformation' - Is it induced by the target cell membrane?
124. New evidence for a membrane-bound pathway in hormone receptor binding
125. On the mechanism of hormone recognition and binding by the CCK-B/gastrin receptor
126. Conformation of a peptide ligand bound to its G-protein-coupled receptor
127. Location and orientation relative to the micelle surface for glucagon in mixed micelles with dodecylphosphocholine
128. Cholecystokinin receptors
129. International union of pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors
130. The peripheral cholecystokinin receptors
131. The tumor biology of gastrin and cholecystokinin
132. CCK receptor antagonists
133. G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: An exemplary family
134. Structurally similar small molecule photoaffinity CCK-A agonists and antagonists as novel tools for directly probing 7TM receptors-ligand interactions
135. Gene structure of human cholecystokinin (CCK) type-A receptor: Body fat content is related to CCK type-A receptor gene promoter polymorphism
136. Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: A strategy for the design of peptidase inhibitors
137. 2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine] as a new template for the design of CCK(2) receptor antagonists
138. Development of peptide 3D structure mimetics: Rational design of novel peptoid cholecystokinin receptor antagonists
139. CCK peptides with combined features of hexa and tetrapeptide CCK-A agonists
140. Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists
141. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin
142. Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state
143. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin
144. Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin
145. Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling
146. Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe
147. Direct identification of a second distinct site of contact between cholecystokinin and its receptor
148. 1H NMR conformational study of sulfated and non-sulfated cholecystokinin fragment CCK27-33: Influence of the sulfate group on the peptide folding
149. Conformational analysis of cholecystokinin fragments CCK4, CCK5, and CCK6 by 1H-NMR spectroscopy and fluorescence-transfer measurements
150. Conformational analysis of cholecystokinin CCK26-33 and related fragments by 1H NMR spectroscopy fluorescence-transfer measurements, and calculations
151. Conformational analysis of the cholecystokinin C-terminal octapeptide: A nuclear magnetic resonance and computer-simulation approach
152. Conformational behavior of cyclic CCK-related peptides determined by 400-MHz 1H-NMR: Relationships with affinity and selectivity for brain receptors
153. Solution conformation of CCK9, a cholecystokinin analog
154. Direct identification of the agonist binding site in the human brain cholecystokinin B receptor